MRNAStock Forecast & Price Prediction
Moderna, Inc. Common Stock · 2026–2027 outlook · as of July 27, 2026
Based on Moderna, Inc. Common Stock's historical trend and volatility, Invest's model projects a 12-month base-case price target of about $48.83 for MRNA — roughly -9.7% from the current $54.07 — within a range of $27.04 (bear) to $76.41 (bull). Invest's signal currently rates MRNA a Hold.
Current price
$54.07
Invest signal
Hold
12-mo expected
-9.7%
Volatility
67%
12-month price targets
Algorithmic scenarios from MRNA's historical trend and volatility.
Momentum and conditions stay favorable.
The trend continues at a measured pace.
Conditions weaken or the trend reverses.
Longer term, extending the base-case trend gives a rough 3-year target near $39.83.
How MRNA has performed
1 month
-10.5%
6 months
+4.2%
1 year
+56.0%
52-week range: $22.28 – $85.60.
How this forecast works: targets are generated by an algorithm from MRNA's historical price trend and volatility, dampened toward a long-run market average. They are illustrative and for educational purposes only — not financial advice. Markets are unpredictable and past performance does not guarantee future results.
Think the forecast is right? Test it — risk-free.
Practice trading MRNA with €1,000,000 in virtual cash at live prices.
Trade MRNAMRNA forecast: FAQ
What is the MRNA stock forecast for 2026–2027?
Invest's model projects a 12-month base-case target of around $48.83 for MRNA (-9.7% from $54.07), with a bull case near $76.41 and a bear case near $27.04. These are algorithmic projections from historical price behavior, not guarantees.
Will MRNA stock go up?
No one can know for certain. Invest's signal weighs MRNA's trend, momentum and valuation and currently reads Hold, after gaining 56% over the past year. The best way to test a thesis is to trade it risk-free in a simulator first.
Is MRNA a good long-term investment?
That depends on your goals and risk tolerance. For context, extending the base-case trend gives a rough 3-year target near $39.83 for MRNA. This is educational information, not financial advice — practice with virtual cash to learn how MRNA behaves before investing real money.
Can I practice trading MRNA for free?
Yes. Invest is a free stock market simulator — start with €1,000,000 in virtual cash and buy or sell MRNA at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.
